89Zr-Bevacizumab
Phase 2 small_molecule active
Quick answer
89Zr-Bevacizumab for NF2-related schwannomatosis is a Phase 2 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- NF2-related schwannomatosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active